Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuberculosis Surveillance in Romania Among Vulnerable Risk Groups Between 2015 and 2017.

Therapeutics and clinical risk management·2022
Same author

Persistent Left Superior Vena Cava - Accidental Finding.

In vivo (Athens, Greece)·2020
Same author

A joint cross-border investigation of a cluster of multidrug-resistant tuberculosis in Austria, Romania and Germany in 2014 using classic, genotyping and whole genome sequencing methods: lessons learnt.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
Same author

[Complex case with respiratory, endocrine and digestive manifestations--late complications after a colic replacement of the esophagus for lye ingestion].

Pneumologia (Bucharest, Romania)·2014
Same author

[The 6th National Conference of the Tabacology Section of the Romanian Society of Pneumology. Pitesti, November 21-23, 2013].

Pneumologia (Bucharest, Romania)·2014
Same author

[Present and future perspectives for the rapid molecular diagnosis of TB and MDR-TB].

Pneumologia (Bucharest, Romania)·2014

Related Experiment Video

Updated: Jun 22, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

[Tuberculosis in Romania between 2006-2008].

Constantin Marica1, Domnica Chiotan, Cristian Didilescu

  • 1Institutul de Pneumologie Marius Nasta, Bucureşti. c_marica2002@yahoo.com

Pneumologia (Bucharest, Romania)
|June 11, 2009
PubMed
Summary

Romania

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Diseases

Background:

  • Tuberculosis (TB) incidence in Romania is high, ranking first in the European Union.
  • A gradual decrease in TB incidence and mortality has been observed in recent years.
  • Multidrug-resistant TB (MDR TB) remains a significant concern, with 800 new cases annually.

Purpose of the Study:

  • To evaluate the efficacy of National Tuberculosis Program (NTP) implementation in Romania.
  • To analyze trends in TB incidence, mortality, and treatment success rates.

Main Methods:

  • Analysis of epidemio-metrical indicators from 2006 to 2008.
  • Evaluation of treatment success rates for new pulmonary TB patients (SS(+) and culture-confirmed).

Related Experiment Videos

Last Updated: Jun 22, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Main Results:

  • TB incidence in Romania decreased from 114.2 to 108 per 100,000 population between 2006 and 2008.
  • Childhood TB incidence and overall TB mortality also showed a downward trend.
  • Treatment success rates for new pulmonary TB patients increased, reaching 83.9% (SS+) and 85.5% (culture-confirmed) in 2006.

Conclusions:

  • The implementation of the National Tuberculosis Program in Romania has been effective.
  • Observed decreases in TB incidence, childhood TB, and mortality, alongside increased treatment success, confirm the efficacy of TB control efforts.